insights_auto
DMYD-B āĻā§āĻ¨ āĻŦā§āĻĄāĻŧā§āĻā§ ā§Š.ā§Ēā§%?
āĻāĻ°āĻ āĻāĻā§āĻ°ā§ āĻāĻŋā§ā§ āĻāĻžāĻ¨ā§āĻ¨chevron_right
DMYD-B:STO
Diamyd Medical AB
ā§§.ā§Ļā§§Â SEK
arrow_upward
+ā§Š.ā§Ēā§%(+ā§Ļ.ā§Ļā§Šā§Ē) ā§§ āĻĻāĻŋ
ā§§ā§¨ āĻ
āĻā§āĻā§, ā§Ģ:ā§¨ā§¯:ā§Ģā§Ž PM GMT +ā§¨ · SEK
search
āĻ¸āĻŦ āĻ¸āĻŋāĻŽā§āĻŦāĻ˛
| āĻ¸āĻŋāĻŽā§āĻŦāĻ˛ | āĻĻāĻžāĻŽ | āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ āĻāĻ°ā§āĻ¨ | % āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|
insights_autoDMYD-B-āĻāĻ° āĻāĻ¨ā§āĻ¯ āĻ¸ā§āĻ°āĻž āĻāĻ¨āĻ¸āĻžāĻāĻ āĻā§āĻ¨āĻžāĻ°ā§āĻ āĻāĻ°āĻž āĻšāĻā§āĻā§...
āĻā§āĻ˛ā§āĻ¨
ā§Ļ.ā§¯ā§ŽÂ SEK
āĻ¸āĻ°ā§āĻŦāĻžāĻ§āĻŋāĻ
ā§§.ā§Ļā§Ē SEK
āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨
ā§Ļ.ā§¯ā§ŽÂ SEK
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Ģ.ā§Šā§Ŧ āĻā§
āĻ
ā§āĻ¯āĻžāĻāĻžāĻ°ā§āĻ āĻāĻ˛āĻŋāĻāĻŽ
ā§.ā§ā§ĒÂ āĻ˛āĻž
āĻāĻ˛āĻŋāĻāĻŽ
ā§.ā§¯ā§Â āĻ˛āĻž
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§ā§.ā§Žā§ŽÂ SEK
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨ āĻĻāĻžāĻŽ
ā§Ļ.ā§¯ā§Ļ SEK
EPS
-ā§§.ā§ā§Ŧ SEK
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ°
ā§§ā§Š.ā§Ēā§Ļ āĻā§
āĻāĻ°ā§āĻŽā§āĻ¸āĻāĻā§āĻ¯āĻž
ā§Ēā§¨
āĻā§āĻ˛ā§āĻ¨
ā§Ļ.ā§¯ā§ŽÂ SEK
āĻ¸āĻ°ā§āĻŦāĻžāĻ§āĻŋāĻ
ā§§.ā§Ļā§Ē SEK
āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨
ā§Ļ.ā§¯ā§ŽÂ SEK
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Ģ.ā§Šā§Ŧ āĻā§
āĻ
ā§āĻ¯āĻžāĻāĻžāĻ°ā§āĻ āĻāĻ˛āĻŋāĻāĻŽ
ā§.ā§ā§ĒÂ āĻ˛āĻž
āĻāĻ˛āĻŋāĻāĻŽ
ā§.ā§¯ā§Â āĻ˛āĻž
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§ā§.ā§Žā§ŽÂ SEK
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨ āĻĻāĻžāĻŽ
ā§Ļ.ā§¯ā§Ļ SEK
EPS
-ā§§.ā§ā§Ŧ SEK
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ°
ā§§ā§Š.ā§Ēā§Ļ āĻā§
āĻāĻ°ā§āĻŽā§āĻ¸āĻāĻā§āĻ¯āĻž
ā§Ēā§¨
āĻāĻ āĻ§āĻ°āĻ¨ā§āĻ° āĻāĻ°āĻ āĻ¸ā§āĻāĻ
āĻāĻŦāĻ°ā§āĻ° āĻ¸ā§āĻā§āĻ°āĻŋ
āĻā§ā§āĻŦ āĻ¸ā§āĻ°ā§āĻ¸ āĻ āĻāĻŦāĻ°ā§āĻ° āĻĒāĻžāĻ°ā§āĻāĻ¨āĻžāĻ°āĻĻā§āĻ° āĻĨā§āĻā§
CNBC
·
ā§Ģā§§ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
New York Post
·
ā§¨ā§¨ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
NYSE's opening bell honors Italian Americans who beat stereotypes to reach pinnacle of finance
Simply Wall Street
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
Qualcomm (QCOM) Makes Its AI Infrastructure Pivot Harder To Ignore
Yahoo Finance
·
ā§Ģ āĻāĻŖā§āĻāĻž āĻāĻā§
Not Sandisk, Not Intel. This Stock Will Lead the S&P 500 Next Year
āĻĒā§āĻ°ā§āĻĢāĻžāĻāĻ˛
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GADââ
, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in UmeÃĨ which utilizes bacuolavirus-mediated protein expression. Wikipedia
Diamyd Medical AB āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
āĻ¸āĻŋāĻāĻāĻāĻ˛āĻĢ āĻšā§āĻ¯āĻžāĻ¨ā§āĻ˛āĻŋāĻ¯āĻŧāĻžāĻ¸
āĻāĻ°ā§āĻŽā§ā§Ēā§¨
āĻĒā§āĻ°āĻ¤āĻŋāĻˇā§āĻ āĻžāĻ° āĻ¤āĻžāĻ°āĻŋāĻā§§ā§¯ā§Žā§Ē
āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°-
āĻ¸ā§āĻā§āĻāĻ°-
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻdiamyd.com